From: Use of antithrombotics at the end of life: an in-depth chart review study
Antithrombotic agent | N= | % | |
---|---|---|---|
VKA | Â | 30 | 19.1 |
phenprocoumon | 1 | 0.6 | |
acenocoumarol | 29 | 18.5 | |
Heparins | Â | 60 | 38.2 |
heparin | 2 | 1.3 | |
dalteparin | 8 | 5.1 | |
enoxaparin | 7 | 4.5 | |
nadroparin | 39 | 24.8 | |
tinzaparin | 4 | 2.5 | |
PAI | Â | 66 | 42.0 |
clopidogrel | 4 | 2.5 | |
dipyridamole | 5 | 3.2 | |
acetylsalicylic acid | 30 | 19.1 | |
carbasalate calcium | 27 | 17.2 | |
Other | fondaparinux | 1 | 0.6 |
 | Total | 157 | 100 |